The online version of this article (doi: https://doi.org/10.1186/s13053-017-0083-8) contains supplementary material, which is available to authorized users.
Extensive clinical and genetic heterogeneity of inherited cancers has allowed multi-gene panel testing to become an efficient means for identification of patients with an inherited predisposition to a broad spectrum of syndromic and nonsyndromic forms of cancer. This study reports our experience with a 27-gene inherited cancer panel on a cohort of 630 consecutive individuals referred for testing at our laboratory with the following objectives: 1. Determine the rates for positive cases and those with variants of uncertain clinical significance (VUS) relative to data published in the recent literature, 2. Examine heterogeneity among the constituent genes on the panel, and 3. Review test uptake in the cohort relative to other reports describing outcomes for expanded panel testing.
Clinical and genomic data were reviewed on 630 individuals tested on a panel of 27 genes selected on the basis of high (≥ 40%) or moderate to low (≤ 40%) lifetime risk of hereditary cancer. These patients were not enriched for adherence to the National Comprehensive Cancer Network (NCCN) criteria for Hereditary Breast and Ovarian Cancer (HBOC) or Lynch Syndrome (LS) and constitute a referral laboratory cohort.
Sixty-five individuals with variants classified as pathogenic or likely pathogenic across 14 genes were identified for an overall positive rate of 10.3%. Although a family history of cancer constituted a major reason for referral, accounting for 84% of our cohort, excluding patients with a known familial variant did not have a significant impact on the observed positive rate (9% vs 10.3%). More than half (58%) of the pathogenic or likely pathogenic variants were observed in high or moderate to low risk genes on the panel, while only 42% occurred in classic HBOC or LS-associated genes.
These results provide the actual percentage of family or personal history of cancer that can be attributed to pathogenic or likely pathogenic variants in one or more of the genes on our panel and corroborate the utility of multi-gene panels over sequential testing to identify individuals with an inherited predisposition to cancer.
Additional file 1: Patient characteristics and variant listing among positive cases, Pathogenic and likely pathogenic variants detected in the study. (XLSX 20 kb)13053_2017_83_MOESM1_ESM.xlsx
Petrucelli N, Daly MB, Pal T. Gene reviews (R): eds R. A. Pagon et al.; 1993.
Hegde M, Ferber M, Mao R, Samowitz W, Ganguly A, Working Group of the American College of Medical G, et al. ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Genet Med. 2014;16:101–16. CrossRefPubMed
Kohlmann W, Gruber SB. Gene reviews (R): eds R. A. Pagon et al.; 1993.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24. CrossRefPubMedPubMedCentral
Exome Aggregation Consortium (ExAC). Cambridge. 2015. http://exac.broadinstitute.org. Accessed March 2017.
Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP). Seattle. http://evs.gs.washington.edu/EVS/. Accessed March 2017.
Genomes Project C, Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56–65. CrossRef
Jenkins MA, Croitoru ME, Monga N, Cleary SP, Cotterchio M, Hopper JL, et al. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiol Biomark Prev. 2006;15:312–4. CrossRef
NCCN Clinical practice guidelines in oncology: genetic/familial high-risk assessment: Colorectal. Version 2. 2017. http://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf. Accessed May 2017.
- Evaluation of a 27-gene inherited cancer panel across 630 consecutive patients referred for testing in a clinical diagnostic laboratory
Sabrina A. Gardner
Katelyn S. Weymouth
Wei S. Kelly
Patricia M. Okamoto
Melissa A. Hayden
- BioMed Central
Neu im Fachgebiet Onkologie
e.Med Kampagnen-Visual, Mail Icon II